5 Feb |
Kerry Inc. Pleads Guilty and Agrees to Pay $19.228 Million in Connection with Insanitary Plant Conditions Linked to 2018 Salmonella Poisoning Outbreak |
The U.S. Department of Justice |
3 Feb |
Bankruptcy Court Finds Cannabis Employee Not Entitled to Chapter 13 Protection |
Mintz |
3 Feb |
FDA Announces Qualified Health Claim for Cocoa Flavanols in High Flavanol Cocoa Powder and Reduced Risk of Cardiovascular Disease |
Keller and Heckman LLP |
3 Feb |
Revamping of Cosmetics Regulation and Safety |
Squire Patton Boggs (US) LLP |
2 Feb |
Food and Chemicals Unpacked: Extended Producer Responsibility: EPR You Ready? [PODCAST] |
Keller and Heckman LLP |
2 Feb |
340B Covered Entities May See Access Changes to Contrast Media, Radiopharmaceuticals and Other Products |
McDermott Will & Emery |
2 Feb |
EU Tightens Checks on Vanilla Extract from US |
Keller and Heckman LLP |
1 Feb |
Not so FAST – AB 257 on Hold Pending Voter Referendum in 2024 |
Jackson Lewis P.C. |
1 Feb |
If at First You Don’t Succeed: Updated Medical Cannabis Bill Filed in South Carolina |
Bradley Arant Boult Cummings LLP |
1 Feb |
Unpacking Averages: Using NLP to Assess FDA’s Compliance with Notice and Comment in Guidance Development |
Epstein Becker & Green, P.C. |
1 Feb |
FDA Announces Proposed Redesign to Create Human Foods Program |
Keller and Heckman LLP |
31 Jan |
Bankruptcy Court Doors Swing Open For Cannabis Companies, But Just Slightly |
Squire Patton Boggs (US) LLP |
31 Jan |
The FDA Gets Blunt: “New Regulatory Pathway for CBD is Needed” |
Dinsmore & Shohl LLP |
31 Jan |
Old North State Report – Jan. 30, 2023 |
Nelson Mullins |
31 Jan |
FDA Issues Final and Draft Guidance Documents Regarding Food Allergen Labeling |
Epstein Becker & Green, P.C. |
31 Jan |
FDA Issues Procedural Notice on Front-of-Package Labeling Research |
Keller and Heckman LLP |
31 Jan |
Are Medical Diagnostic Methods Patent Ineligible by Convention?: CareDx, Inc. v. Natera, Inc. and Eurofins Viracor, Inc. |
K&L Gates |
31 Jan |
This Week in 340B: January 24 – 30, 2023 |
McDermott Will & Emery |
30 Jan |
FDA Announces Important Shift in CBD Products Regulation |
Bradley Arant Boult Cummings LLP |
30 Jan |
FDA Finalizes Guidance to Prevent Unsafe Contamination of Animal Feed from Drug Carryover |
Keller and Heckman LLP |
29 Jan |
Beltway Buzz, January 27, 2023 |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
27 Jan |
FDA Concludes that New Regulatory Frameworks for Foods and Supplements Containing Cannabidiol are Needed, Will Work with Congress |
Keller and Heckman LLP |
26 Jan |
FDA Passes New Cannabis Guidance for Clinical Research |
Beveridge & Diamond PC |
26 Jan |
2023 Federal Forecast – Agriculture |
ArentFox Schiff LLP |
26 Jan |
Do the Products You Sell Contain PFAS? |
Hunton Andrews Kurth |
26 Jan |
Cannabis: Goin’ to Carolina in My Mind |
Bradley Arant Boult Cummings LLP |
25 Jan |
Further Restrictions on Food and Drink Labeling |
OLIVARES |
25 Jan |
Modernization of Cosmetics Regulation Act of 2022: What You Need to Know |
Foley & Lardner LLP |
25 Jan |
FDA Finalizes Cannabis Guidance Focusing on Clinical Research and Quality Considerations |
Nelson Mullins |
25 Jan |
Costco’s Motion to Dismiss Misleading “Dolphin-Safe” Canned Tuna Class Action Denied |
Keller and Heckman LLP |
24 Jan |
Take a Bite out of Crime: There’s More than One Way to Stem the Flow of Counterfeit Medications |
Womble Bond Dickinson (US) LLP |
24 Jan |
Heavy Metal Updates: FDA Releases Draft Guidance with Action Levels for Lead and Another Heavy Metal Lawsuit Dismissed |
Keller and Heckman LLP |
24 Jan |
Removing the Green Tax: Congress Can Bring Cannabis Tax Policy in Line with Cannabis Enforcement Policy |
Bradley Arant Boult Cummings LLP |
23 Jan |
High Stakes: What to do Now That Your New Jersey Cannabis Business Application Has Been Approved by the CRC |
Stark & Stark |
23 Jan |
What Can the Agriculture Sector Expect from Rep. Andy Harris on Agriculture and BioTech Appropriations |
ArentFox Schiff LLP |
23 Jan |
USDA Finalizes the Strengthening Organic Enforcement Rule |
Keller and Heckman LLP |
20 Jan |
Where In the World Did My Food Come From: FDA’s Food Traceability Rule Takes Effect |
ArentFox Schiff LLP |
20 Jan |
French NGO Claims Certain Everyday Products Contain Unlabeled Nanomaterials |
Bergeson & Campbell, P.C. |
20 Jan |
FDA Approval Mifepristone REMS Program Modification Expands Patient Access to Abortion Care |
Sheppard, Mullin, Richter & Hampton LLP |
20 Jan |
USDA Expands Generic Label Approval for Meat, Poultry, and Egg Products |
Keller and Heckman LLP |
19 Jan |
Preparing a Cannabis Application: Five Things I Learned |
Bradley Arant Boult Cummings LLP |
18 Jan |
Congress Enacts Modernization of Cosmetics Regulation Act of 2022, Significantly Strengthening Regulation of Cosmetics |
Bergeson & Campbell, P.C. |
18 Jan |
What’s Old Is New Again: Reviving “Fairness” With Renewed FTC Price Discrimination Enforcement And What That Means For Companies |
Polsinelli PC |
18 Jan |
Recent Federal Developments in Chemical Law January 2023 |
Bergeson & Campbell, P.C. |
18 Jan |
First Major Overhaul of Cosmetics Regulation Since FDR Administration |
Nelson Mullins |
18 Jan |
Plaintiffs Allege Failure to Declare Presence of Additives on Sparkling Water Label is Misleading |
Keller and Heckman LLP |
17 Jan |
CMS Proposed Rule for Refunding Overpayments Would Align With False Claims Act “Knowledge” Standard |
Mintz |
17 Jan |
Is Texas Getting Ready to Expand Its Compassionate Use Program? |
Bradley Arant Boult Cummings LLP |
17 Jan |
Court Rules that “Brown Bread” is Not Misleading |
Keller and Heckman LLP |
17 Jan |
Prop 65 Roundup - January 2023 |
ArentFox Schiff LLP |
17 Jan |
EPA’s Fall 2022 Unified Agenda Includes Proposed and Final TSCA and TRI Rules |
Bergeson & Campbell, P.C. |
16 Jan |
Cannabis Lounges Coming to New Jersey |
Norris McLaughlin P.A. |
13 Jan |
SweNanoSafe Publishes Notes from Fifth Annual Research Network Workshop |
Bergeson & Campbell, P.C. |
13 Jan |
After Almost 25 Years, FTC Issues New Health Products Compliance Guidance |
McDermott Will & Emery |
13 Jan |
Lead in your Spice Rack? |
Womble Bond Dickinson (US) LLP |
13 Jan |
DEA Chopping Block: DATA-Waiver Requirement |
Foley & Lardner LLP |
13 Jan |
FDA’s Center for Food Safety and Applied Nutrition Continues Evaluation of Heavy Metals in Food and Child Development |
Keller and Heckman LLP |
13 Jan |
Higher Prices in Pennsylvania and Liquor Law Reform in New Jersey |
Norris McLaughlin P.A. |
12 Jan |
USDA Releases Report on State Animal Welfare Policies |
Keller and Heckman LLP |
11 Jan |
California Will Soon Protect Employees’ Off-Duty Cannabis Use |
Greenberg Traurig, LLP |
11 Jan |
FDA Finalizes FSVP Guidance for Importers of Human and Animal Food |
Keller and Heckman LLP |
10 Jan |
Cosmetics Regulations Get a Makeover: Congress Enacts New Requirements |
Keller and Heckman LLP |
10 Jan |
Class Action Targets “No Artificial Sweeteners Claim” |
Keller and Heckman LLP |
10 Jan |
FDA’s Holiday Present from Congress: Bipartisan Reforms to the Accelerated Approval Framework, Long-Awaited Cosmetic Modernization, and Expansion of Certain Existing Programs |
Mintz |
10 Jan |
Get Your Restaurant Business Fit to Transact in 2023 |
Greenberg Traurig, LLP |
10 Jan |
10 Steps to Import Your Dream Horse and Minimize Risk Along the Neigh |
Greenberg Traurig, LLP |
10 Jan |
BETO Announces New Notice of Intent for Improving Bioenergy Feedstocks and Optimizing Production of Biofuels and Biochemicals |
Bergeson & Campbell, P.C. |
10 Jan |
GT Legal Food Talk Episode 18: Regulatory Review – Looking Back and Forward [PODCAST] |
Greenberg Traurig, LLP |
10 Jan |
Cannabis Growers and Processors Must Be Aware of Applicable Environmental Laws |
Varnum LLP |
9 Jan |
2023 Labor and Employment Outlook for Manufacturers |
Robinson & Cole LLP |
9 Jan |
The Commission has Issued a Long-Awaited Proposal to Amend the CLP Regulation |
Keller and Heckman LLP |
9 Jan |
FDA Removes L. monocytogenes From Protocol for the Development and EPA Registration of Treatments for Preharvest Agricultural Water |
Keller and Heckman LLP |
9 Jan |
Highest French Administrative Court Lifts the Ban on CBD Flowers and Leaves |
Squire Patton Boggs (US) LLP |
8 Jan |
Multinational Corporation and Several Individuals Charged with Multimillion-Dollar Organic Grain Fraud Scheme |
The U.S. Department of Justice |
7 Jan |
Medical Device Company Zyno Medical LLC Agrees To Pay Nearly $500,000 To Resolve False Claims Act Allegations Relating to Defective Medical Device |
The U.S. Department of Justice |
7 Jan |
CBP Officers at the San Ysidro Port of Entry Seize Over $2 Million Worth of Cocaine |
U.S. Customs and Border Protection |
6 Jan |
Perrigo Co. v. Abbvie Inc. - Third Circuit Holds Mutual Release Bars Generic Drug Company’s Antitrust Claim Alleging That “Sham” Patent Infringement Litigation Delayed Generic Drug Launch |
K&L Gates |
6 Jan |
District of Columbia Medical Cannabis Amendment Act Makes Sweeping Changes to Local Cannabis Laws |
ArentFox Schiff LLP |
6 Jan |
FDA Issues Uniform Compliance Date for Final Food Labeling Regulations in 2023-24 |
Keller and Heckman LLP |
6 Jan |
TTB Industry Circular 3: Calculating Tax Rates and Tax Credits on Imported Distilled Spirits |
McDermott Will & Emery |
6 Jan |
2022 TTB Industry Circular 2: Social Media Advertising |
McDermott Will & Emery |
6 Jan |
2022 TTB Industry Circular 1: Consignment Sales |
McDermott Will & Emery |
6 Jan |
Sweet (But Not Too Sugary) Victory: Court Dismisses Lawsuit Over Sprout Foods Baby Food Labeling |
Proskauer Rose LLP |
5 Jan |
Breakthrough FDA Decision: Agency Completes Its First Pre-Market Consultation for Human Food Made from Cultured Animal Cells |
K&L Gates |
5 Jan |
Biden Administration Publishes Unified Agenda, Revealing FDA’s Planned Regulatory Actions for 2023 |
Nelson Mullins |
5 Jan |
Foods Produced from Animal Cells: What’s in a Name? |
Keller and Heckman LLP |
5 Jan |
Sesame Listed as Major Food Allergen |
Keller and Heckman LLP |
5 Jan |
ANDA Filing Alone Insufficient for Induced Infringement of Method Patent |
McDermott Will & Emery |
5 Jan |
If You Don’t Believe, You Won’t Receive: Predicting Three Cannabis Reforms in the Coming Year |
Bradley Arant Boult Cummings LLP |
4 Jan |
Petition Filed to Add Polyphenylene Sulfide to List of Chemical Substances Subject to Superfund Excise Tax |
Bergeson & Campbell, P.C. |
4 Jan |
IDR Payment Disputes are Far Outpacing Projections, Creating Backlogs |
Squire Patton Boggs (US) LLP |
4 Jan |
California Judge Temporarily Enjoins Implementation of FAST Recovery Act |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
4 Jan |
Target’s Fruit Punch Water Enhancer Class Action Permanently Dismissed |
Keller and Heckman LLP |
3 Jan |
Cosmetic Regulatory Reform Finally Becomes Law |
Mintz |
3 Jan |
2022, Who Were You? A Recap of Hot Issues in 2022. |
Bradley Arant Boult Cummings LLP |
3 Jan |
FDA Releases 2022 Edition of the Food Code |
Keller and Heckman LLP |
3 Jan |
A Way Too Early Prediction: Alabama Cannabis 2.0 |
Bradley Arant Boult Cummings LLP |
31 Dec |
China to Remove Infringing Pharmaceuticals from Procurement Platforms |
Schwegman, Lundberg & Woessner, P.A. |
30 Dec |
Potential Litigation Impacts of the Modernization of Cosmetics Regulation Act of 2022 |
Greenberg Traurig, LLP |
30 Dec |
Companies Gear Up For Mass Production of Cultured Meat |
Womble Bond Dickinson (US) LLP |
30 Dec |
New Cosmetic Regulatory Requirements: What Cosmetic Manufacturers Need to Know |
Greenberg Traurig, LLP |
29 Dec |
Mississippi Medical Cannabis, Charles Dickens Style |
Bradley Arant Boult Cummings LLP |
29 Dec |
Welcome (but Last Minute) Relief for Prescription Drug Reporting Originally Due December 27 |
McDermott Will & Emery |
29 Dec |
Petition Filed to Add Polyoxymethylene to List of Chemical Substances Subject to Superfund Excise Tax |
Bergeson & Campbell, P.C. |
29 Dec |
Doctor-Patient Relationships and Medical Marijuana: Where Are We Now? |
McDermott Will & Emery |
28 Dec |
EPA Finds Carbon Tetrachloride, as a Whole Chemical Substance, Poses an Unreasonable Risk to Human Health |
Bergeson & Campbell, P.C. |
28 Dec |
Consolidated Appropriations Act, 2023 Contains Significant Provisions for Cosmetic Products |
ArentFox Schiff LLP |
28 Dec |
RxDC Reporting Relief for Plans, Issuers, and Plan Service Providers |
Foley & Lardner LLP |
28 Dec |
Federal Regulators Offer Employer Health Plans Last-Minute Relief on Prescription Drug Reporting |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
27 Dec |
EPA Announces Removal of PFAS Chemicals from Approved Inert Ingredient List for Pesticide Products |
Bergeson & Campbell, P.C. |
27 Dec |
FDA Expands Inspection Guidance to Apply to Device Manufacturers |
Sheppard, Mullin, Richter & Hampton LLP |
24 Dec |
Back to the Drawing Board: CMS Proposes Changing the Overpayment Rule’s “Identified” Definition |
McDermott Will & Emery |
24 Dec |
The Greatest Gift of All…Tri-Agencies Issue Welcome Relief on Prescription Drug Reporting |
Proskauer Rose LLP |
23 Dec |
OECD Accepting Comment on Draft Study Report on Applicability of the key event based TG 442D for in vitro skin sensitisation testing of nano-materials |
Bergeson & Campbell, P.C. |
22 Dec |
Omnibus Bill for Fiscal Year 2023 (H.R. 2617) – Cosmetics Summary |
Keller and Heckman LLP |
22 Dec |
Consumer Reports Evaluates Heavy Metals in Chocolate |
Keller and Heckman LLP |
22 Dec |
Heinz PFAS Consumer Fraud Lawsuit Continues 2022 Trend |
CMBG3 Law |
21 Dec |
PTO Expands the Scope of the Immunotherapy Pilot Program |
Schwegman, Lundberg & Woessner, P.A. |
21 Dec |
ANSES Applies Methodology to Assess Risks of Nanomaterials in Food to Titanium Dioxide |
Bergeson & Campbell, P.C. |
21 Dec |
FTC Revises Longstanding “Dietary Supplement Guide” to Cover all Health Products |
Hunton Andrews Kurth |
21 Dec |
FDA Issues Final Guidance on GRAS Panel Best Practices |
Keller and Heckman LLP |
20 Dec |
Comment Period for “Healthy” Regulations Extended; But Consumer Class Actions Targeting “Health Halos” May Continue |
Sheppard, Mullin, Richter & Hampton LLP |
20 Dec |
OSTP Publishes RFIs on Coordinated Framework for the Regulation of Biotechnology and National Biotechnology and Biomanufacturing Initiative |
Bergeson & Campbell, P.C. |
20 Dec |
Mississippi Department of Health Releases Proposed Modifications to Medical Cannabis Regulations |
Bradley Arant Boult Cummings LLP |
20 Dec |
California Legislative Update Part II: Upcoming Changes for Health Facilities |
Mintz |
20 Dec |
Office of Science and Technology Policy Requests Public Input on Biotechnology Regulation |
Keller and Heckman LLP |
19 Dec |
340B Hospital Reimbursement Update – Underpayments and the Need to Act Now |
Polsinelli PC |
19 Dec |
Proposed Changes to the Canadian Feed Ingredients Table |
Keller and Heckman LLP |
16 Dec |
FTC Starts Long-Awaited Green Guides Review |
Keller and Heckman LLP |
16 Dec |
EUON Announces Results of Desk Study on (Bio)degradation, Persistence, and SbD of Nanomaterials |
Bergeson & Campbell, P.C. |
15 Dec |
Psychedelic Drugs – Easing the Regulatory Hurdles for Development |
Foley & Lardner LLP |
15 Dec |
Economically Motivated Adulteration in Honey |
Keller and Heckman LLP |
15 Dec |
China Announces New Management Measures for Food-Related Products |
Keller and Heckman LLP |
14 Dec |
FDA Published Food Safety Culture Literature Review |
Keller and Heckman LLP |
13 Dec |
California’s Newly Adopted “Safe Harbor” Warning Label for Acrylamide In Foods Turns Up the Heat In Ongoing First Amendment Challenge to Proposition 65 |
Sheppard, Mullin, Richter & Hampton LLP |
13 Dec |
FDA Letter States that β-Nicotinamide Mononucleotide is Not Lawful Dietary Supplement |
Keller and Heckman LLP |
13 Dec |
Warning Sign? A New Round of FDA Warning Letters Over CBD Consumer Confusion May Signal a Shift in Government Enforcement |
Bradley Arant Boult Cummings LLP |
12 Dec |
American Hospital Association Urges DEA to Issue Special Registration for Telemedicine Controlled Substances |
Foley & Lardner LLP |
12 Dec |
“Cold-Pressed Juice” Lawsuit Permanently Dismissed |
Keller and Heckman LLP |
10 Dec |
HHS Goes Back to The Drawing Board on the 340B ADR Process |
McDermott Will & Emery |
8 Dec |
FDA Releases Traceability Final Rule |
K&L Gates |
8 Dec |
Like a Steam Locomotive, Rolling Down the Track: Biden Signs Marijuana Research Bill |
Bradley Arant Boult Cummings LLP |
8 Dec |
DOJ Weighs in on SAFE Banking Act, Requests “Minor Changes” |
ArentFox Schiff LLP |
8 Dec |
FSIS and FDA Continue to Investigate Food-Borne Illnesses |
Keller and Heckman LLP |
8 Dec |
USDA Seeks Applications for Grants to Help Rural Businesses Produce and Market Value-Added Products |
U.S. Department of Agriculture |
7 Dec |
Materials Available from EPA’s NAMs Conference and CompTox Chemicals Dashboard Training |
Bergeson & Campbell, P.C. |
7 Dec |
External Evaluation of FDA’s Human Foods Program Published |
Keller and Heckman LLP |
7 Dec |
New Law Eases Federal Restrictions on Medical Marijuana Research and Cultivation |
ArentFox Schiff LLP |
6 Dec |
Don’t Let Drugs Bring You Down: The Importance of an Effective Drug Diversion Program |
Sheppard, Mullin, Richter & Hampton LLP |
6 Dec |
USDA Receives Petition Requesting Amendment to Import for Personal Consumption Regulation |
Keller and Heckman LLP |